Argentina

 

Eugin sells for €500m

Healthcare conglomerate Fresenius has sold Eugin, its Spain-based fertility business, to KKR-owned fertility group IVI RMA and Spain-based asset management firm GED for €500m including earn-outs.
November 10, 2023

Mubadala-backed M42 buying Diaverum “for $2bn+”

Swedish multinational dialysis firm Diaverum is being bought by M42, a joint venture between Abu Dhabi sovereign wealth fund Mubadala Investment Co and AI firm G42, for a reported $2bn-$2.5bn. Diaverum’s CEO tells HBI the deal offers further opportunities to develop its digital strategies, and international expansion. 
April 19, 2023

Diaverum deal: An analysis

Last week the news broke that Abu Dhabi sovereign wealth fund Mubadala Investment Co might be set to buy Swedish multinational dialysis firm Diaverum for a reported $2.5bn. HBI speaks to an operator source who thinks this would be a good price for the seller - and hears why some investors are switched off by dialysis.
April 6, 2023

Top Doctors raises $13m to boost growth

Top Doctors, the third biggest doctor-booking platform in private healthcare after EU-based Doctolib and global player DocPlanner, has raised $13m to improve its digital tools and grow in key sectors. HBI chats with Alberto E. Porciani, CEO of Top Doctors to find out more.
October 14, 2021

Elderly care post-Covid: HBI Big Picture Seminar

How has Covid affected the elderly care sector across EMEA? To find out, HBI-365, the new global digital platform, brought together a panel of three: Fredrik Gren, CEO and president, Ambea, a sophisticated and large Pan-Scandinavian care group, Alexei Sidnev, CEO, Senior Group, the largest player in a big emerging market, Russia and Pierre-Emanuel Bercegeay, CEO, Ouihelp, a VC-backed, digital-savvy domiciliary homecare start-up in France. The seminar was followed by the first meeting of our HBI-365 elderly community with a useful roundtable on workforce.
July 2, 2020

From homecare to hotels

In Argentina a domiciliary homecare group has taken over three hotels to offer accommodation to Covid-symptomatic patients. What does this say about the wider links between hotels and care homes in Emerging Markets?
June 23, 2020

Bridgepoint “exploring” €2bn sale/IPO of Diaverum

As first reported by HBI, dialysis group Diaverum looks certain to be sold by Bridgepoint. Reuters now suggests that Diaverum is "exploring" and "testing the appetite" for a €2bn sale of the global dialysis group Diaverum. We go through potential buyers.
August 1, 2019

Interview: Dimitris Moulavasilis, CEO, Diaverum 

Will international dialysis group Diaverum IPO or sell? We catch up with its new CEO, the former boss of international imaging group Affidea. Rarely have we met such an enthusiastic leader. That may be just as well. Many wonder whether Diaverum, which has been owned by private equity house Bridgepoint since 2007, can ever be sexed up enough to attract a top price. If anyone can achieve this, it is Moulavasilis. 
July 3, 2019

Opportunities in LATAM

Panellists on the LatAm panel at HBI 2019 see good opportunities in the region thanks to booming demand, particularly as demographics shift from rural to urban bases, and with the growth of the chronic and elderly care markets. Increasing use of digital health tools and better data, plus the growth of the consumer market are also seen as positive factors for the market.
May 28, 2019
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us